Moxifloxacine Sandoz (Moxifloxacin)

• Moxifloxacine Sandoz is a fluoroquinolone antibiotic indicated for several bacterial infections.
• Community‑acquired pneumonia: achieves clinical cure and microbiological eradication in adults.
• Acute bacterial sinusitis: reduces symptoms and clears the infection.
• Acute bacterial exacerbation of chronic bronchitis: improves lung function and resolves bacterial flare‑ups.
• Skin and skin‑structure infections: eliminates pathogenic bacteria and promotes healing.
• Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed bacterial flora.

• Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By binding to these enzymes, the drug prevents the supercoiling and separation of DNA strands, leading to bacterial cell death and a bactericidal effect against susceptible organisms.

Moxifloxacine Sandoz may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Abdominal pain
• Rash

Serious or Rare Side Effects

• Tendon rupture or inflammation
• QT interval prolongation leading to arrhythmia
• Clostridioides difficile‑associated colitis
• Severe allergic reactions such as anaphylaxis
• Hepatic dysfunction
• Peripheral neuropathy

• Before prescribing Moxifloxacine Sandoz, clinicians should consider several safety aspects.
• Renal or hepatic impairment: adjust therapy based on clinical judgment.
• History of tendon disorders: avoid use or monitor closely.
• QT interval prolongation risk: avoid in patients with known cardiac arrhythmias or concomitant QT‑prolonging drugs.
• Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited.
• Drug interactions: review concomitant medications for potential interactions.
• Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Moxifloxacine Sandoz can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Co‑administration with systemic corticosteroids: increased risk of tendon rupture.
• Concurrent use with other fluoroquinolones: additive toxicity.
• Combination with drugs that prolong QT interval (e.g., quinidine, macrolides): heightened risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely)

• Antacids containing aluminum or magnesium, or iron/calcium supplements: may reduce absorption.
• Warfarin: may enhance anticoagulant effect; monitor INR.
• Theophylline: possible increase in plasma concentration.